164 related articles for article (PubMed ID: 23780896)
1. Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma.
Feng CC; Ding GX; Song NH; Li X; Wu Z; Jiang HW; Ding Q
Tumour Biol; 2013 Dec; 34(6):3471-6. PubMed ID: 23780896
[TBL] [Abstract][Full Text] [Related]
2. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Papworth K; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
[TBL] [Abstract][Full Text] [Related]
5. Higher expression of K-ras is associated with parathyroid hormone-related protein-induced hypercalcaemia in renal cell carcinoma.
Kamai T; Arai K; Koga F; Abe H; Nakanishi K; Kambara T; Furuya N; Tsujii T; Yoshida KI
BJU Int; 2001 Dec; 88(9):960-6. PubMed ID: 11851621
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma.
Ding GX; Feng CC; Song NH; Fang ZJ; Xia GW; Jiang HW; Hua LX; Ding Q
Urol Oncol; 2013 Nov; 31(8):1820-5. PubMed ID: 22534085
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of parathyroid hormone related protein (PTHrP) in renal cell carcinoma].
Gotoh A; Kitazawa S; Fukase M; Ogawa T; Arakawa S; Fujimori T; Maeda S; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):588-92. PubMed ID: 2051695
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
9. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.
Schweitzer DH; Boxman IL; Löwik CW; van Krieken JH; Weissglas MG; Baatenburg de Jong RJ; Papapoulos SE
J Clin Pathol; 1995 Oct; 48(10):896-900. PubMed ID: 8537484
[TBL] [Abstract][Full Text] [Related]
11. Production of parathyroid hormone-related protein in two new cell lines of renal cell carcinoma.
Ueno M; Akita M; Ban SI; Ohigashi T; Yanagita S; Iida M; Deguchi N
Int J Urol; 2001 Oct; 8(10):549-56. PubMed ID: 11737483
[TBL] [Abstract][Full Text] [Related]
12. Correlation of VEGF and EGFR in peripheral blood with clinical stage and pathological grade of renal cell carcinoma and analysis of prognosis.
Chu C; Lu C; Zhang Z; Zhao C; Gu M; Yang A; Ma B; Xin Z; Cui R; Wu M; Huang T; Zhou W
J BUON; 2018; 23(4):1097-1102. PubMed ID: 30358217
[TBL] [Abstract][Full Text] [Related]
13. Humoral hypercalcaemia in renal carcinoma due to parathyroid hormone related protein.
Sandhu DP; Munson KW; Harrop JS; Hopton MR; Ratcliffe WA
Br J Urol; 1993 Dec; 72(6):848-50. PubMed ID: 8306145
[TBL] [Abstract][Full Text] [Related]
14. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
15. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
Chang BD; Cao LS; Zhou HL
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.
Iwamura M; Wu W; Muramoto M; Ohori M; Egawa S; Uchida T; Baba S
Cancer; 1999 Sep; 86(6):1028-34. PubMed ID: 10491530
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
18. Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.
Ljungberg B; Jacobsen J; Häggström-Rudolfssson S; Rasmuson T; Lindh G; Grankvist K
Urol Res; 2003 Oct; 31(5):335-40. PubMed ID: 14574539
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of erythropoietin in renal cell carcinoma.
Noguchi Y; Goto T; Yufu Y; Uike N; Hasegawa Y; Fukuda T; Jimi A; Funakoshi A
Intern Med; 1999 Dec; 38(12):991-4. PubMed ID: 10628941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
